Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Andy Hsieh is an analyst at William Blair. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/26/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 02/28/2025 | CRBP | Buy Now | Corbus Pharmaceuticals | $6.10 | — | Andy Hsieh20% | — | Initiates | → Outperform | Get Alert |
| 02/28/2025 | SKYE | Buy Now | Skye Bioscience | $2.38 | — | Andy Hsieh20% | — | Initiates | → Outperform | Get Alert |
| 02/28/2025 | ALT | Buy Now | Altimmune | $5.96 | — | Andy Hsieh20% | — | Initiates | → Market Perform | Get Alert |
| 02/28/2025 | TERN | Buy Now | Terns Pharma | $3.38 | — | Andy Hsieh20% | — | Initiates | → Market Perform | Get Alert |
| 02/28/2025 | GPCR | Buy Now | Structure Therapeutics | $20.52 | — | Andy Hsieh20% | — | Initiates | → Outperform | Get Alert |
| 02/28/2025 | BIOA | Buy Now | Bioage Labs | $4.25 | — | Andy Hsieh20% | — | Initiates | → Market Perform | Get Alert |
| 02/06/2025 | MRSN | Buy Now | Mersana Therapeutics | $0.45 | — | Andy Hsieh20% | — | Initiates | → Outperform | Get Alert |
| 01/03/2025 | ELEV | Buy Now | Elevation Oncology | $0.28 | — | Andy Hsieh20% | — | Initiates | → Outperform | Get Alert |
| 11/21/2024 | PYXS | Buy Now | Pyxis Oncology | $1.18 | — | Andy Hsieh20% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 03/19/2024 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | Andy Hsieh20% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 02/12/2024 | CBAY | Buy Now | CymaBay Therapeutics | — | — | Andy Hsieh20% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 12/26/2023 | RYZB | Buy Now | RayzeBio | — | — | Andy Hsieh20% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 10/06/2023 | RYZB | Buy Now | RayzeBio | — | — | Andy Hsieh20% | — | Initiates | → Outperform | Get Alert |
| 09/29/2023 | LNTH | Buy Now | Lantheus Holdings | $99.77 | — | Andy Hsieh20% | — | Initiates | → Outperform | Get Alert |
| 08/03/2023 | ARAV | Buy Now | Aravive | — | — | Andy Hsieh20% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 06/26/2023 | FGEN | Buy Now | FibroGen | $0.35 | — | Andy Hsieh20% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 04/05/2023 | CBAY | Buy Now | CymaBay Therapeutics | — | — | Andy Hsieh20% | — | Initiates | → Outperform | Get Alert |
| 02/21/2023 | ATNM | Buy Now | Actinium Pharma | $1.58 | — | Andy Hsieh20% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 01/31/2023 | FGEN | Buy Now | FibroGen | $0.35 | — | Andy Hsieh20% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 07/06/2022 | PNT | Buy Now | POINT Biopharma Global | — | — | Andy Hsieh20% | — | Initiates | → Outperform | Get Alert |
| 07/06/2022 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | Andy Hsieh20% | — | Initiates | → Outperform | Get Alert |
| 08/23/2021 | ICVX | Buy Now | Icosavax | — | — | Andy Hsieh20% | — | Initiates | → Outperform | Get Alert |
| 05/25/2021 | VACC | Buy Now | Vaccitech | — | — | Andy Hsieh20% | — | Initiates | → Outperform | Get Alert |
